Lv5
1040 积分 2024-09-11 加入
A Mechanistic Pharmacokinetic/Pharmacodynamic Model of Factor D Inhibition in Cynomolgus Monkeys by Lampalizumab for the Treatment of Geographic Atrophy
1天前
已完结
Monoclonal Antibody Against Prolactin Receptor: A Randomized Placebo-Controlled Study Evaluating Safety, Tolerability, and Pharmacokinetics of Repeated Subcutaneous Administrations in Postmenopausal Women
1个月前
已完结
A Review on Forced Degradation Strategies to Establish the Stability of Therapeutic Peptide Formulations
3个月前
已完结
Industry Perspective on Therapeutic Peptide Drug–Drug Interaction Assessments During Drug Development: A European Federation of Pharmaceutical Industries and Associations White Paper
3个月前
已完结
The Current State of Peptide Drug Discovery: Back to the Future?
3个月前
已完结
Trends in peptide drug discovery
3个月前
已完结
Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist
4个月前
已关闭
Structural and Functional Aspects of RGD-Containing Cyclic Pentapeptides as Highly Potent and Selective Integrin αVβ3Antagonists
4个月前
已完结
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial
5个月前
已完结
Spontaneous protein–protein crosslinking at glutamine and glutamic acid residues in long-lived proteins
6个月前
已完结
皖公网安备34019202002308
